Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus‐associated cirrhosis

Many studies have demonstrated in animal experiments that persistent inflammation may accelerate the development of carcinoma. In this article, the question of whether the persistent elevation of serum alanine aminotransferase (ALT) levels (which represents the inflammatory necrosis of hepatocytes) correlates with the development of hepatocellular carcinoma (HCC) was studied in patients with early stage hepatitis C virus (HCV)‐associated cirrhosis.

• Publication year

  1999

• Venue

  Cancer

• Publication date

  1999-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0142(19990815)86:4<589::AID-CNCR7>3.0.CO;2-KPMID 10440686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus‐associated cirrhosis and HCC

  1997influential reference
• The long term efficacy of glycyrrhizin in chronic hepatitis C patients

  1997cited by this paper
• Hepatoma and medicine medical care. The hepatoma. The setting of a high risk group. A forecast of the canceration from liver cirrhosis. C type liver cirrhosis is done central.

  1995cited by this paper
• [Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].

  1995cited by this paper
• Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma.

  1995cited by this paper
• Prospective study of chemoprevention of hepatocellular carcinoma with sho‐saiko‐to (TJ‐9)

  1995cited by this paper
• Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

  1995cited by this paper
• Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.

  1994cited by this paper
• Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti‐hepatitis C virus‐positive cirrhotic patients

  1994cited by this paper
• The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase.

  1994cited by this paper
• Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C.

  1994cited by this paper
• Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients.

  1994cited by this paper
• Role of Increased DNA Synthesis Activity of Hepatocytes in Multicentric Hepatocarcinogenesis in Residual Liver of Hepatectomized Cirrhotic Patients with Hepatocellular Carcinoma

  1994influential reference
• Prospective study of α‐fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

  1994cited by this paper
• The role of hepatitis C virus in hepatocellular carcinoma in Japan.

  1994cited by this paper
• A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis

  1993cited by this paper
• [Non-A, non-B/C hepatitis].

  1993cited by this paper
• Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial.

  1993cited by this paper
• Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis.

  1992cited by this paper
• Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

  1990influential reference
• A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis

  1989cited by this paper
• Early recognition of hepatocellular carcinoma

  1986cited by this paper
• Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.

  1986cited by this paper
• Hepatocellular carcinoma detected by iodized oil.

  1985cited by this paper
• Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

  1982cited by this paper
• Inhibition of tumor initiation and promotion by anti-inflammatory agents.

  1973cited by this paper
• The liver and portal hypertension

  1964cited by this paper
• Surgery and portal hypertension.

  1964cited by this paper

• High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C.

  2025cites this paper
• Investigating pathogenic SNP of PKCι in HCV-induced hepatocellular carcinoma

  2023cites this paper
• Recurrence Patterns After Hepatectomy With Very Narrow Resection Margins for Hepatocellular Carcinoma

  2022cites this paper
• Analyzing PKC Gamma (+ 19,506 A/G) polymorphism as a promising genetic marker for HCV-induced hepatocellular carcinoma

  2022cites this paper
• The relationship between hepatitis C - related hepatocellular carcinoma and IL-23 receptor gene polymorphism

  2022cites this paper
• Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment

  2021cites this paper
• Coumarin: An emerging antiviral agent

  2020cites this paper
• Financial Burden of Liver Transplant vs Resection for Hepatocellular Carcinoma.

  2019cites this paper
• Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment

  2019cites this paper
• B lymphocytes limit senescence‐driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury

  2018cites this paper
• Moderate intensity low frequency rotating magnetic field inhibits breast cancer growth in mice

  2018cites this paper
• Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma

  2017cites this paper
• miR-223 and Stathmin-1 Expression in Non-tumor Liver Tissue of Patients with Hepatocellular Carcinoma.

  2017cites this paper
• Influence of polymorphisms in the Wnt/β-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population

  2017influential citation
• A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.

  2017cites this paper
• Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.

  2016cites this paper
• Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients

  2016cites this paper
• Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice*

  2016cites this paper
• Dietary sugar intake increases liver tumor incidence in female mice

  2016cites this paper
• Prostaglandin E-Major Urinary Metabolite as a Biomarker for Inflammation in Ulcerative Colitis: Prostaglandins Revisited

  2016cites this paper
• Studies on the epidemiology of HCV have suggested that the Nile delta region of Egypt has one of the highest prevalence rates of HCV infection in the world with seroprevalence rates approaching 20% in villagers over the age

  2015cites this paper
• Long-term stability of cancer biomarkers in human serum: biomarkers of oxidative stress and redox status, homocysteine, CRP and the enzymes ALT and GGT.

  2015cites this paper
• Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.

  2015cites this paper
• Does herbal medicine reduce the risk of hepatocellular carcinoma?

  2015cites this paper
• Hepatocellular carcinoma risk assessment using gadoxetic acid‐enhanced hepatocyte phase magnetic resonance imaging

  2014cites this paper
• Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

  2014cites this paper
• Specific miRNA expression profiles of non‐tumor liver tissue predict a risk for recurrence of hepatocellular carcinoma

  2014cites this paper
• Post-treatment levels of α-fetoprotein predict incidence of hepatocellular carcinoma after interferon therapy.

  2014cites this paper
• Rheumatoid factor interference of α-fetoprotein evaluations in human serum by ELISA.

  2014cites this paper
• Increased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients

  2014cites this paper
• Inhibitory potential of methanolic extracts of Aristolochia tagala and Curcuma caesia on hepatocellular carcinoma induced by diethylnitrosamine in BALB/c mice

  2014cites this paper
• Inflammation in background cirrhosis evokes malignant progression in HCC development from HCV-associated liver cirrhosis

  2013cites this paper
• MARCATORI MOLECOLARI AD IMPATTO TRASLAZIONALE NEL CARCINOMA EPATOCELLULARE

  2013cites this paper
• 559 hemophiliacs infected with the hepatitis C virus Six-month versus 12-month surveillance for hepatocellular carcinoma in

  2013cites this paper
• Protection Against Cyclophosphamide-Induced Myelosuppression by ZPDC Glycoprotein (24 kDa)

  2013cites this paper
• High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.

  2013cites this paper
• Hepatitis C Virus and Hepatocellular Carcinoma

  2013influential citation
• Comparison between hepatic resection and radiofrequency ablation as first‐line treatment for solitary small‐sized hepatocellular carcinoma of 3 cm or less

  2013cites this paper
• Ameliorative effect of methanol extract of Rubia cordifolia in N-nitrosodiethylamine-induced hepatocellular carcinoma

  2012influential citation
• Variabilité génétique du virus de l’hépatite virale C.

  2012cites this paper
• Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.

  2012cites this paper
• APASL consensus statements and management algorithms for hepatitis C virus infection

  2012cites this paper
• A blue native polyacrylamide gel electrophoretic technology to probe the functional proteomics mediating nitrogen homeostasis in Pseudomonas fluorescens.

  2012cites this paper
• Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks

  2012cites this paper
• Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis.

  2012cites this paper
• Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ‐specific chronic inflammation‐carcinoma sequence

  2012cites this paper
• Severe inflammation in the background liver cirrhosis correlates with the development of poorly differentiated HCC in HCV-associated liver cirrhosis.

  2012cites this paper
• Efficacy and Anticarcinogenic Activity of Ribavirin Combination Therapy for Hepatitis C Virus-Related Compensated Cirrhosis

  2012cites this paper
• Activity of tumor necrosis factor-α blocked by phytoglycoprotein (38 kDa) at initiation stage in N-nitrosodiethylamine-induced ICR mice

  2012cites this paper
• Efficacy of MK615 for the treatment of patients with liver disorders.

  2012cites this paper
• Inhibitory effect of phytoglycoprotein (24 kDa) on hepatocarcinogenesis in N‐nitrosodiethylamine‐treated ICR mice

  2011cites this paper
• Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C

  2011cites this paper
• Therapeutic effects of the oriental herbal medicine Sho‐saiko‐to on liver cirrhosis and carcinoma

  2011cites this paper
• Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C

  2011cites this paper
• Inhibitory effect of SJSZ glycoprotein (38 kDa) on expression of heat shock protein 27 and 70 in chromium (VI)-treated hepatocytes

  2011cites this paper
• Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development

  2011cites this paper
• Molecular characteristics of non‐cancerous liver tissue in non‐B non‐C hepatocellular carcinoma

  2011cites this paper
• Prediction of Hepatocellular Carcinoma Development by Plasma ADAMTS13 in Chronic Hepatitis B and C

  2011cites this paper
• Antitumor activity of NPB001-05, an orally active inhibitor of Bcr-Abl tyrosine kinase.

  2011cites this paper
• Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.

  2011cites this paper
• The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis

  2011cites this paper
• Polymorphisms of Tumor Necrosis Factor-Alpha and Hepatocellular Carcinoma Risk: A HuGE Systematic Review and Meta-Analysis

  2011cites this paper
• Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma

  2010cites this paper
• Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus

  2010cites this paper
• Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

  2010cites this paper
• Integrated fibrosis scoring by ultrasonography predicts the occurrence of hepatocellular carcinoma in patients with chronic hepatitis C virus infection

  2010cites this paper
• C型慢性肝疾患（慢性肝炎・肝硬変症）難治例に対して十全大補湯は第3の肝庇護剤になりえるか

  2010cites this paper
• Chemopreventive effect of bacoside A on N-nitrosodiethylamine-induced hepatocarcinogenesis in rats

  2010cites this paper
• HCC develops even in the early stage of chronic liver disease in elderly patients with HCV infection.

  2010cites this paper
• Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis.

  2010cites this paper
• Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.

  2009cites this paper
• Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection

  2009cites this paper
• High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis

  2009cites this paper
• Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepatocellular carcinoma in Italian patients

  2009cites this paper
• Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers.

  2009cites this paper
• Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation

  2009cites this paper
• Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case–control study

  2009cites this paper
• 3. Chronic Hepatitis and Liver Cancer

  2008cites this paper
• An Analysis of Risk Factors for Developing Hepatocellular Carcinoma in a Group of Hepatitis C Patients with Stage 3 Fibrosis following Interferon Therapy

  2008cites this paper
• Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus

  2008cites this paper
• Hepatitis C virus and its roles in cell proliferation

  2008cites this paper
• Association of Ki67 with raised transaminases in hepatocellular carcinoma.

  2008cites this paper
• Interaction between interleukin-1beta -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese.

  2008cites this paper
• 1. Hepatic Carcinogenesis Associated with Viral Hepatitis

  2008cites this paper
• Relation between incidence of hepatic carcinogenesis and integration value of alanine aminotransferase in patients with hepatitis C virus infection

  2007cites this paper
• Overexpressed cyclo‐oxygenase‐2 in the background liver is associated with the clinical course of hepatitis C virus‐related cirrhosis patients after curative surgery for hepatocellular carcinoma

  2007cites this paper
• [Novel formulations of a liver protection drug glycyrrhizin].

  2007cites this paper
• Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon‐resistant active chronic hepatitis C

  2007cites this paper
• Analysis of hepatitis C virus-specific CD8+ T-cells with HLA-A*24 tetramers during phlebotomy and interferon therapy for chronic hepatitis C.

  2007cites this paper
• Univariate and multivariate analysis of prognostic factors in the surgical treatment of hepatocellular carcinoma in cirrhotic patients.

  2006cites this paper
• Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress

  2006cites this paper
• Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases.

  2006cites this paper
• Effects of triterpene compounds on cytotoxicity, apoptosis, and immune response in cultured cells

  2006cites this paper
• Celecoxib induces regression of putative preneoplastic lesions in rat liver.

  2006cites this paper
• A Long-Term Glycyrrhizin Injection Therapy Reduces Hepatocellular Carcinogenesis Rate in Patients with Interferon-Resistant Active Chronic Hepatitis C: A Cohort Study of 1249 Patients

  2006cites this paper
• Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.

  2006cites this paper
• Specific Gene-Expression Profiles of Noncancerous Liver Tissue Predict the Risk for Multicentric Occurrence of Hepatocellular Carcinoma in Hepatitis C Virus–Positive Patients

  2006influential citation
• Prognostic Evaluation of the New American Joint Committee on Cancer/International Union Against Cancer Staging System for Hepatocellular Carcinoma: Analysis of 112 Cirrhotic Patients Resected for Hepatocellular Carcinoma

  2005cites this paper
• Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy

  2005influential citation
• Interferon reduces somatic mutation of mitochondrial DNA in liver tissues from chronic viral hepatitis patients

  2005cites this paper